nach oben

Clinical Autonomic Research

Erschienen in:

01.10.2015 | Research Article

Prevention of recurrent autonomic dysreflexia: a survey of current practice

verfasst von: Deborah Caruso, David Gater, Christopher Harnish

Erschienen in: Clinical Autonomic Research | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

There is a dearth of literature on the treatment of chronic recurrent autonomic dysreflexia (AD), a well-known complication of spinal cord injury that can have life-threatening implications. This study sought to identify clinical practices regarding the treatment of AD, both acute and recurrent, in patients with spinal cord injury (SCI).

Methods

Online survey regarding AD management in SCI composed of 11 questions designed to obtain information on respondent characteristics, AD treatment options, and causes of AD.

Setting

Veterans Administration health care system.

Participants

Veterans Health Administration National SCI Staff Physicians were sent an electronic email to participate in the anonymous web-based survey.

Intervention

None applicable.

Results

The response rate was 52 %. The most commonly prescribed medications for minor and severe acute manifestations of AD were nitrates. For recurrent AD, clonidine was the most commonly prescribed medication.

Interpretation

Anti-hypertensive medications continue to be the mainstay in the management of both acute and chronic recurrent AD. Current literature is lacking in prospective randomized controlled trials investigating the relative efficacy of AD interventions. Evidence-based practice guidelines are necessary to improve clinical care.

Krassioukov A, Warburton D, Teasell R, Eng J (2009) A systematic review of the management of autonomic dysreflexia after spinal cord injury. Arch Phys Med Rehabil 37:383–391

Curt A, Nitsche B, Rodic B, Schurch B, Dietz V (1997) Assessment of autonomic dysreflexia in patients with cord injury. J Neurol Neurosurg Psychiatry 62:473–477PubMedCentralCrossRefPubMed

Elliot S, Krassioukov A (2006) Malignant autonomic dysreflexia in spinal cord injured men. Spinal Cord 44:386–392CrossRef

Karlsson AK (1999) Autonomic Dysreflexia. Spinal Cord. 37:383–391CrossRefPubMed

Braddom R, Rocco J (1991) Autonomic dysreflexia—a survey of current treatment. Am J Phys Med Rehabil 70(5):234–241CrossRefPubMed

Weaver L (2002) What causes autonomic dysreflexia after spinal cord injury? Clin Auton Res 12:424–426CrossRefPubMed

Leman S, Sequeira H (2002) Activation of adrenal preganglionic neurons during autonomic dysreflexia in the chronic spinal cord-injured rat. Auton Neurosci 98:94–98CrossRefPubMed

Consortium for Spinal Cord Medicine (2002) Acute management of autonomic dysreflexia: adults with spinal cord injury presenting to health care facilities. J Spinal Cord Med 25:S67–S88

Erickson RP (1980) Autonomic hyperreflexia: pathophysiology and medical management. Arch Phys Med Rehab. 61:431–440

10.

Rabchevsky A, Kitzman P (2011) Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury. Neurotherapeutics 8:274–282PubMedCentralCrossRefPubMed

11.

Drug monographs-nitroglycerin. www.mdconsult.com. Accessed 20 September 2014

12.

Grossman E, Messerli FH, Grodzicki T, Kowey P (1996) Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 276(16):1328–1331CrossRefPubMed

13.

http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf. Accessed 20 July 2014

14.

Crassous PA, Denis C, Paris H, Sénard JM (2007) Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr Top Med Chem 7(2):187–194CrossRefPubMed

15.

Drug monographs-prazosin. www.mdconsult.com. Accessed 20 September 2014)

16.

Chancellor MB, Erhard MJ, Hirsch IH, Stass WE Jr (1994) Prospective evaluation of terazosin for treatment of autonomic dysreflexia. J Urol 151:111–113PubMed

17.

Luther RR (1989) Terazosin: a new antihypertensive with a favorable effect on lipids. Int J Clin Pharmacol Ther Toxicol 27(7):313–319PubMed

18.

Drug monographs-terazosin. www.mdconsult.com. Accessed 01 April 2014)

19.

Dessì-Fulgheri P, Bandiera F, Rubattu S et al (1987) Comparison of sublingual and oral captopril in hypertension. Clin Exp Hypertens 9(2–3):593–597

20.

Esmail Z, Shalansky KF, Sunderji R et al (2002) Evaluation of captopril for the management of hypertension in autonomic dysreflexia: a pilot study. Arch Phys Med Rehabil 83(5):604–608CrossRefPubMed

21.

Braddom RL, Johnson EW (1969) Mecamylamine in control of hyperreflexia. Arch Phys Med Rehabil 50:448–453PubMed

22.

Frishman WH (2009) Smoking cessation pharmacotherapy. Ther Adv Cardiovasc Dis 4:287–308CrossRef

23.

Hall PA, Young JV (1983) Autonomic hyperreflexia in spinal cord injured patients: trigger mechanism-dressing changes of pressure sores. J Trauma 23:1074–1075CrossRefPubMed

24.

Wright KD, Agre JC, Wilson BC, Theologides A (1986) Autonomic dysreflexia in a paraplegic man with catecholamine secreting neuroblastoma. Arch Phys Med Rehabil 67:566–567PubMed

25.

Vaidyanathan S, Soni BM, Sett P, Watt JW, Oo T, Bingley J (1998) Pathophysiology of autonomic dysreflexia: long-term treatment with terazosin in adult and pediatric spinal cord injury patients manifesting recurrent dysreflexic episodes. Spinal Cord 36:761–770CrossRefPubMed

26.

Krum H, Louis WJ, Brown DJ, Howes LG (1992) A study of the alpha-1 adrenoreceptor blocker prazosin in the prophylactic management of autonomic dysreflexia in high spinal cord injury patients. Clin Auton Res 2(2):83–88CrossRefPubMed

27.

Lindan R, Leffler E, Kedia K (1985) A comparison of the efficacy of an alpha 1 adrenergic blocker in the slow calcium channel blocker in the control of autonomic dysreflexia. Paraplegia 23:34–38CrossRefPubMed

28.

McGuire EJ, Wagner FM, Weiss RM (1977) Treatment of autonomic dysreflexia. J Urol 118:70–72

29.

Sizemore GW, Winternitz WW (1970) Autonomic hyper-reflexia—suppression with alpha-adrenergic blocking agents. N Engl J Med 282(14):795CrossRefPubMed

30.

Shessel FS, Carrion HM, Politano VA (1978) Phenoxybenzamine and sweating in the spinal cord injury patient. J Urol 120(1):60–61PubMed

31.

Guyton AC, Hall JE (2000) Textbook of medical physiology. W.B. Saunders Company, Philadelphia

32.

Scott MB, Morrow JW (1978) Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury. J Urol 199:483–484

33.

Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139:919–922PubMed

34.

Gamé X, Castel-Lacanal E, Bentaleb Y et al (2008) Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 53(3):613–618 Epub 2007 Aug 28 CrossRefPubMed

35.

Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Costantini E, Porena M (2004) Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol 172:240–243CrossRefPubMed

36.

MacDonald R, Fink HA, Huckabay C, Monga M, Wilt TJ (2007) Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects. Spinal Cord 45(8):535–541 Epub 2007 Apr 24 CrossRefPubMed

37.

Giannantoni A, Di Stasi SM, Stephen RL et al (2002) Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol 167(4):1710–1714CrossRefPubMed

38.

Igawa Y, Satoh T, Mizusawa H et al (2003) The role of capsaicin-sensitive afferents in autonomic dysreflexia in patients with spinal cord injury. BJU Int 91(7):637–641CrossRefPubMed

39.

Barton CH, Khonsari F, Vaziri ND, Byrne C, Gordon S, Friis R (1986) The effect of modified transurethral sphincterotomy on autonomic dysreflexia. J Urol 135(1):83–85PubMed

40.

Perkash I (2007) Transurethral sphincterotomy provides significant relief in autonomic dysreflexia in spinal cord injured male patients: long-term followup results. J Urol 177(3):1026–1029CrossRefPubMed

41.

Ricottone AR, Pranikoff K, Steinmetz JR, Constantino G (1995) Long-term follow-up of sphincterotomy in the treatment of autonomic dysreflexia. Neurourol Urodyn 14(1):43–46CrossRefPubMed

42.

Teichman JM, Harris JM, Currie DM, Barber DB (1998) Malone antegrade continence enema for adults with neurogenic bowel disease. J Urol 160(4):1278–1281CrossRefPubMed

43.

Hohenfellner M, Pannek J, Botel U (2001) Sacral bladder denervation for treatment of detrusor hyperreflexia and autonomic dysreflexia. Urology 58:28–32CrossRefPubMed

44.

Pannek J, Göcking K, Bersc U (2010) Sacral rhizotomy: a salvage procedure in a patient with autonomic dysreflexia. Spinal Cord 48:347–348CrossRefPubMed

45.

Kofler M, Poustka K, Saltuari L (2009) Intrathecal baclofen for autonomic instability due to spinal cord injury. Auton Neurosci 146:106–110CrossRefPubMed

46.

Creasey GH, Grill JH, Korsten M et al (2001) Implanted Neuroprosthesis Research Group: an implantable neuroprosthesis for restoring bladder and bowel control to patients with spinal cord injuries: a multicenter trial. Arch Phys Med Rehabil 82:1512–1519CrossRefPubMed

Titel: Prevention of recurrent autonomic dysreflexia: a survey of current practice
verfasst von: Deborah Caruso
David Gater
Christopher Harnish
Publikationsdatum: 01.10.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Autonomic Research / Ausgabe 5/2015
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI: https://doi.org/10.1007/s10286-015-0303-0

Neu in den Fachgebieten Neurologie und Psychiatrie

25.04.2024 | Hypotonie | Nachrichten

Springer Medizin

Prevention of recurrent autonomic dysreflexia: a survey of current practice

Abstract

Objective

Methods

Setting

Participants

Intervention

Results

Interpretation

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Springer Medizin

Abstract

Objective

Methods

Setting

Participants

Intervention

Results

Interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2015

Orthostatic hypotension is associated with decreased cerebrospinal fluid levels of chromogranin A in early stage of Parkinson disease

Looking for a standardized approach in the surgical treatment of hyperhidrosis

In response: looking for a standardized approach in the surgical treatment of hyperhidrosis

Cerebral blood flow during HUTT in young patients with orthostatic intolerance

Evidence of increased cardiac parasympathetic drive in subjects meeting current physical activity recommendations

Sympathotomy for palmar hyperhidrosis: the cutting versus clamping methods

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet